INVO Fertility (IVF) Payables (2010 - 2026)

INVO Fertility (IVF) has 17 years of Payables data on file, last reported at $2.5 million in Q1 2026.

• On a quarterly basis, Payables fell 72.55% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.5 million, a 72.55% decrease from a year earlier, with the FY2025 full-year figure at $3.9 million, down 1.97% from the prior year.
• Payables for Q1 2026 stood at $2.5 million, down from $3.9 million in the prior quarter.
• Over the last five years, Payables for IVF reached as high as $9.3 million in Q1 2025 and fell as low as $462211.0 in Q1 2022.
• Historically, Payables has averaged $3.1 million across 5 years, with a median of $2.7 million in 2023.
• Across the five-year window, Payables jumped 466.24% in 2023 and slumped 72.55% in 2026, its largest moves.
• Year by year, Payables stood at $2.0 million in 2022, then jumped by 59.59% to $3.2 million in 2023, then increased by 24.4% to $4.0 million in 2024, then slipped by 1.97% to $3.9 million in 2025, then slumped by 34.91% to $2.5 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $2.5 million in Q1 2026, $3.9 million in Q4 2025, and $2.5 million in Q3 2025.